Rating History for Gain Therapeutics (GANX) by Roth/MKM

More Stocks Rated by Roth/MKM | Latest Ratings for GANX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/22/2025 Boobalan Pachaiyappan Maintain Buy
(N/A)		 10.00
(6.00)		  
 		   Details